Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Seroma 4Melanoma 3Postoperative Complications 2Breast Neoplasms 2Vulvar Neoplasms 1Stomach Neoplasms 1Lymphoma, Follicular 1Lymphocele 1Lymphedema 1Hemorrhage 1Carcinoma, Squamous Cell 1Bone Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 71apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × Fibrin Tissue Adhesive × Clear all
NCT03733639 2020-07-23

Tisseel® as a Reinforcement of Esophagojejunal Anastomoses

Germans Trias i Pujol Hospital

Phase 4 Unknown
146 enrolled
Gastrointestinal

Stomach Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡